Jubilant Cadista Pharmaceuticals, Inc. recalls Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, Manufactured by:
Jubilant Cadista Pharmaceuticals recalls 5mg Olanzapine orally disintegrating tablets due to subpotent risk. This may affect prescription medication safety. Contact for details.
Lower-risk recall
Subpotent
Contact the company & request your remedy
What happened, in plain English
Jubilant Cadista Pharmaceuticals is recalling 5mg Olanzapine orally disintegrating tablets because they may not contain enough active ingredient. This could lead to ineffective treatment if used as prescribed. Read more at govinfonow.com/recall/36699-jubilant-cadista-olanzapine-tablets-recall-subpotent-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/36699-jubilant-cadista-olanzapine-tablets-recall-subpotent-risk · Updated October 4, 2026 · FDA enforcement record: FDA #D-0066-2021
Cite this page
“Jubilant Cadista Olanzapine Tablets Recall: Subpotent Risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36699-jubilant-cadista-olanzapine-tablets-recall-subpotent-risk. Based on FDA recall #D-0066-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0066-2021%22&limit=1).
Why it’s dangerous
Subpotent means the tablets may not have enough active ingredient to be effective. This could result in the medication not working properly for patients who need it.
Who’s affected
Prescription patients using the recalled Olanzapine tablets. Those with mental health conditions requiring this medication are most at risk.
How to tell if you have this one
Look for the product name 'Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count' in blister packs. The NDC code is 59746-0306-32 and lot number AE119001A with an expiration date of 01/2021.
- Brand
Jubil: Cadista- Category
Drug
What to do — step by step
Check Medication Details
Verify the product name, NDC code, and expiration date to confirm if your tablets are recalled.
Questions people ask
Is this product safe to use?
The recall is due to subpotent risk, meaning the tablets may not contain enough active ingredient. They are not safe for effective treatment.
How can I check if my tablets are recalled?
Check the product name, NDC code (59746-0306-32), and expiration date (01/2021) on the blister pack.
What should I do if I have the recalled product?
The recall does not specify a remedy, so contact your healthcare provider for guidance.
Contact Jubil: Cadista
We’ve drafted a message you can send Jubil: Cadista to request your refund or repair — edit it as you like.
Subject: Recall D-0066-2021 — Jubil: Cadista Jubil: Cadista Hello, I own a Jubil: Cadista that is covered by recall D-0066-2021 from Jubil: Cadista. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0066-2021 (October 26, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0066-2021 to see it in context.
- Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.